Reigniting the cancer-immunity cycle with nanoparticles for simultaneous delivery of oncolytic peptides and a TLR agonist
Bảo Lộc Nguyễn(Yeungnam University), Siyoon Kim(Yeungnam University), Chang‐Hyun Song(Daegu Haany University), Duc‐Vinh Pham(Hanoi University of Pharmacy), Han‐Gon Choi(Hanyang University), Sung Giu Jin(Dankook University), Ngoc Duy Le(Yeungnam University), Cao Dai Phung(National University of Singapore), Jae‐Hoon Chang(Yeungnam University), Jong Oh Kim(Yeungnam University), Jeonghwan Kim(Oregon State University), Sae‐Kwang Ku(Daegu Haany University), Thi Oanh Oanh Nguyen(Yeungnam University)
Cited by 6
Related Papers
Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells
|Pharmaceutics|2019|127
Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming
|Journal of Experimental & Clinical Cancer Research|2022|122
Progressive slowdown/prevention of cellular senescence by CD9-targeted delivery of rapamycin using lactose-wrapped calcium carbonate nanoparticles
|Scientific Reports|2017|113
AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway
|Molecular Cancer|2021|81
Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells
|Nature Communications|2023|71